App-Quantinova.ai

Infusion related reactions (IRRs) and early toxicities of Daratumumab: Single centre experience

S. Munireddy - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Peripheral neuropathy

Dexamethasone

Response of Velcade Dexamethasone Thalidomide (VTD) Chemotherapy in patients suitable for Autologous Stem Cell transplant in Myeloma; experience of District General Hospital

H. Vijayenthiran - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Multiple Myeloma

Dexamethasone

Forward View in Multiple Myeloma: Streamlining Care at Diagnosis, a Tertiary Centre Experience

R.J. Shaw - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal insufficiency

Methadone hydrochloride

Real life experience of MGUS follow up – can we streamline our approach?

R. Peck - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Lymphomas

N/A

Abnormal bone marrow signal on MRI heralding oncologic diagnoses

M. Pavon-Mengual - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Neuroblastoma

N/A

Life‐threatening Hypereosinophilic Syndrome in a 7 year old child

Y.L.T. Chan - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypereosinophilic Syndrome

Methylprednisolone

Lipopolysaccharide (LPS)‐responsive and beige‐like anchor protein deficiency:Unifying diagnosis of multiple autoimmune conditions and immunedeficiency

C. Amadi-Obi - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Immune thrombocytopenia

Methylprednisolone

Challenges in the management of congenital Factor VII deficiency with inhibitors

J. Patel - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Factor VII deficiency

Prothrombin complex

Combined skin lesions of leukaemia cutis and septic emboli in a child with relapsed acute lymphoblastic leukaemia

M. Pavon-Mengual - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute myelocytic leukemia

N/A

Ask the patients‐ a structured survey of patient voices to prioritise research questions in rare inherited anaemias: the James Lind Alliance Priority Setting Partnership

J. Welch - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Psychology in a Sickle Cell & Thalassaemia Service for Adults: An Audit

D.-K. Osakonor - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sickle cell anemia

N/A

Recurrent orbital compression syndrome: A rare presentation of vaso‐occlusive crisis in sickle cell disease

A. Deshpande - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sickle cell anemia

Hydroxycarbamide

A Campaign to Improve Early Recognition and Appropriate Management of the Acute Chest Syndrome in Sickle Cell Disease

D.A. Tsitsikas - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute chest syndrome

N/A

Learning from EQA: the Delta Dilemma

D. Chohan - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Regular Automated Red Cell Exchange Transfusion in the Management of Recurrent Retinal Haemorrhages in Sickle Cell Disease

A. Agapidou - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Sickle cell anemia

Hydroxyurea

The importance of genetic testing in thrombocytopenias

F. Oyesanya - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Macrothrombocytopenia

Prednisolone

Improving Adherence to NICE Guidelines for Investigation of Malignancy in Unprovoked DVT: A Single Centre Experience

E. Millen - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Superficial Vein Thrombosis

N/A

Dabigatran overdose requiring multiple doses of idaricuzimab; clinical and laboratory features

L. Nelmes - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Idarucizumab

Use of extended half‐life Factor VIII and IX concentrates in haemophilia: a clinical audit

P. Elder - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

Recombinant Factor VIII

A Novel Approach for Improving Compliance with Venous Thromboembolism (VTE) Risk Reassessment in Patients Undergoing Endoscopy for Acute Gastrointestinal (GI) Bleed

R. Hargreaves - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Filters

45280 Abstracts